Osteogenesis imperfecta: advancements in genetics and treatment

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Bone mineral density response rates are greater in patients treated with abaloparatide compared with those treated with placebo or teriparatide: Results from the ACTIVE phase 3 trial2018 · 66 citations
2. 2Two years’ experience with denosumab for children with Osteogenesis imperfecta type VI2014 · 125 citations
3. 3Positive Linear Growth and Bone Responses to Growth Hormone Treatment in Children With Types III and IV Osteogenesis Imperfecta: High Predictive Value of the Carboxyterminal Propeptide of Type I Procollagen2003 · 118 citations
4. 4A multicenter study to evaluate pulmonary function in osteogenesis imperfecta2018 · 46 citations